"Recommendations concerning regulatory and legal aspects" contribution to the European task force on disease modifying trials in Alzheimer's disease.
Rapp
L
L
International Regulatory Group; Watson, Farley and Williams LLP London, Paris office.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic / Q000941:ethics / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005060:Europe; D006801:Humans; D012107:Research Design